Yale approves Clearmind Medicine patient recruitment for CMND-100 trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to Yale approves Clearmind Medicine patient recruitment for CMND-100 trial
(NASDAQ: CMND) Delayed: 0.80 -0.06 (6.98%)
Previous Close $0.86    52 Week High $ 
Open $0.85    52 Week Low $ 
Day High $0.86    P/E N/A 
Day Low $0.77    EPS $ 
Volume 194,696